The inclusion of NLRP3-driven inflammation adds additional impetus to such treatment because it has been manifested that NLRP3 activation in various tissues can activate NK cell responses, which may contribute to tumor clearance [77]. This evidence concerns the gene NLRP3 and neoplasm.